Intraday volume spike in CTQ.AX Careteq Limited ASX 07 Feb 2026: short-term liquidity test

We see a large intraday volume spike in CTQ.AX stock on 07 Feb 2026 that pushed trades to the session high. Careteq Limited (CTQ.AX) is trading at A$0.011 with 9,369,364.00 shares changing hands today, well above its average volume of 214,979.00. The jump in liquidity is the main driver of the move and creates a short-term trading window. We examine technical signals, company fundamentals, and what the volume surge means for prices and risk on the ASX in Australia.

Intraday price action and volume spike

CTQ.AX stock opened at A$0.012 and hit a day high of A$0.014 and a low of A$0.01. Volume today is 9,369,364.00, giving a relative volume of 43.58x the 50-day average and signalling a true liquidity event.

One clear fact: the intraday spike is driven by traded volume, not a sustained change in reported fundamentals. Traders should watch whether volume stays elevated through the close.

Technical read: momentum, trend and overbought flags

Momentum indicators are mixed for CTQ.AX stock. The RSI is 54.48, near neutral, while ADX at 28.20 indicates a strengthening trend. The MFI sits at 82.20, which reads as overbought on short timeframes.

On balance, the volume spike increases short-term volatility. Day traders can use the day high A$0.014 as a resistance reference and intraday support near A$0.01.

Fundamental snapshot and sector context

Careteq Limited operates in Healthcare software and assistive living SaaS. The company shows revenue per share 0.042642 and EPS -0.01. Market cap is roughly A$2,608,306.00, and shares outstanding are 237,118,720.00.

Compared with the Healthcare sector (avg PE 32.06, avg PB 5.07), CTQ.AX stock has a lower PB at 1.29 but higher debt-to-equity at 1.56, which raises leverage risk versus peers. Earnings remain negative and cash per share is modest at 0.005851.

Meyka AI grade and model forecast

Meyka AI rates CTQ.AX with a score out of 100: 67.25 (B) — HOLD. This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. These grades are for information only and are not financial advice.

Meyka AI’s forecast model projects a 12-month price of A$0.00991, compared with the current A$0.011, implying a downside of -9.86%. Forecasts are model-based projections and not guarantees.

Risks, catalysts and upcoming events

Key risks for CTQ.AX stock include continued negative EPS, higher leverage, and low free cash flow. The company lists an earnings announcement on 2026-03-02, which could trigger moves if numbers surprise.

Catalysts that could lift the stock are stronger SaaS contract wins, improved operating cash flow, or strategic partnerships in aged care. Absent visible revenue acceleration, volatility may remain high.

Trading strategy and liquidity considerations

For intraday traders, the volume spike creates scalping and liquidity opportunities. Use tight stops given the stock’s small market cap and rapid swings. A short-term target is the session high A$0.014 and immediate support near A$0.01.

Longer-term investors should weigh fundamentals and the Meyka forecast before adding CTQ.AX stock to a portfolio. See our CTQ profile for live data: Meyka CTQ profile.

Final Thoughts

Today’s intraday volume spike in CTQ.AX stock highlights an active trading window but not a clear fundamental break for Careteq Limited on the ASX in Australia. Price sits at A$0.011 with a pronounced volume surge to 9,369,364.00, raising intraday volatility and providing short-term trading opportunities. Meyka AI’s forecast model projects A$0.00991 over 12 months, implying -9.86% versus today’s price. Short-term intraday target: A$0.014 (day high). Multi-month scenarios range from a conservative A$0.010 to a downside case near A$0.006 if cash flow and revenue fail to improve. Remember the company’s debt-to-equity of 1.56 and negative EPS increase risk for longer-term holders. We recommend monitoring volume continuation, the earnings announcement on 2026-03-02, and sector moves in Healthcare. Meyka AI, an AI-powered market analysis platform, will update forecasts if new material information arrives. Forecasts are model-based projections and not guarantees.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.